Anticoagulant therapy in COVID‐19: A narrative review

Anticoagulant therapy in COVID‐19: A narrative review

Abstract Coronavirus disease 2019 (COVID‐19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), can manifest itself in several ways, including coagulopathy and thrombosis. These complications can be the first and sometimes only manifestations of SARS‐CoV‐2 infection and can...

Full description

Bibliographic Details
Main Authors: Zeinab Mohseni Afshar, Ali Tavakoli Pirzaman, Rezvan Hosseinzadeh, Arefeh Babazadeh, Mohamad Ali Taghizadeh Moghadam, Seyed Rouhollah Miri, Terence T. Sio, Mark J. M. Sullman, Mohammad Barary, Soheil Ebrahimpour
Format: Article
Language:English
Published: Wiley 2023-09-01
Series:Clinical and Translational Science
Online Access:https://doi.org/10.1111/cts.13569

Internet

https://doi.org/10.1111/cts.13569

Similar Items